Joe C Mathew / New Delhi July 24, 2008, 0:03 IST
Two United States senators have asked the US Food and Drug Administration (USFDA) to provide details of market approvals given to all medicines sold by India's largest drug-maker Ranbaxy in that country.
The senators, John Dingell and Bart Stupak, also want the FDA inspectors who were in charge of drug approvals for Ranbaxy to appear before a House of Representatives committee by the end of August.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/us-cong-seeks-details-ranbaxy-drug-approvals
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-standard-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-america-us
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ranbaxy-pharmaceuticals